Broad pipeline of clinical stage assets. Birinipant, a bivalent SMAC mimetic read out positive Ph 1/2 combo (keytruda) data; currently in Phase 2 MSS CRC with interim data in 4Q19. MIV-818 is in Phase 1/2 in advanced liver cancer indication with early POC Ph 1a data in 2Q19; Phase 1b to start in 4Q19. Remetinostat in Ph 2 ISS study for BCC, positive interim data announced in 2Q19. BD/licencing opportunities: Ph 3 ready MIV-711 for OA and Ph 3 ready remetinostat for CTCL.
100MM - 500MM
Huddinge, SE-141 22
Send Message to Request Information
Log in to download presentation, request a 1x1 meeting, view additional roadshows, and more.
Upcoming Company Event Participation
Solebury Trout Management Access: SF 2020
San Francisco, CA, United States,
January 13 –
January 16, 2020
Stock Market Data
Market Data copyright © 2019 QuoteMedia.
Data delayed 15 minutes unless otherwise indicated (view
delay times for all
exchanges). RT=Real-Time, RTB=Real-Time
BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time
NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of
Day, PD=Previous Day. Market Data powered by